Chondrocyte container and method of use
First Claim
1. A method for delivering a therapeutic agent to a surgical site, comprising:
- utilizing a delivery device comprising a cell chamber, an auxiliary fluid chamber, and an expandable chamber;
the auxiliary fluid chamber being positioned between the cell chamber and the expandable chamber;
disposing a plurality of chondrocytes in the cell chamber, the cell chamber being configured to retain the chondrocytes, and further configured to allow for release of a therapeutic agent produced by the chondrocytes;
delivering the delivery device to a surgical site; and
delivering the therapeutic agent from the device to the surgical site.
3 Assignments
0 Petitions
Accused Products
Abstract
Devices and methods for delivering a therapeutic agent produced via a genetically-altered chondrocyte are provided. More specifically, the device includes a housing which defines a cell chamber configured to retain a large volume of chondrocytes while selectively releasing therapeutic agents produced via these entrapped cells. In an exemplary embodiment, the cell chamber can be configured such that a portion of cells can be positioned at least about 1.5 mm from an external wall of the device (i.e., about 1.5 mm away from an external nutrient supply). For example, the cell chamber can have a tubular configuration having a length and a diameter wherein each of these dimensions is at least about 3 mm (thereby the central core to the chamber is at least about 1.5 mm from the outer wall of the device).
-
Citations
10 Claims
-
1. A method for delivering a therapeutic agent to a surgical site, comprising:
-
utilizing a delivery device comprising a cell chamber, an auxiliary fluid chamber, and an expandable chamber;
the auxiliary fluid chamber being positioned between the cell chamber and the expandable chamber;disposing a plurality of chondrocytes in the cell chamber, the cell chamber being configured to retain the chondrocytes, and further configured to allow for release of a therapeutic agent produced by the chondrocytes; delivering the delivery device to a surgical site; and delivering the therapeutic agent from the device to the surgical site. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10)
-
Specification